1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
692F2211DF801BC2865258242001D2BBA
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/videos/launching-oncology-products-in-the-us-marketplace?opendocument
18
19opendocument
2018.205.176.85
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25Main






Home >> Video Gallery >> Launching Oncology Products in the US Marketplace

Launching Oncology Products in the US Marketplace

 


In an increasingly crowded US oncology market, it is imperative for bio-pharma companies to plan and execute their oncology portfolio launches seamlessly.

This Best Practices LLC's study equips oncology launch teams with evidence-based benchmarks around investment, staffing and timing requirements to successfully launch new oncology drugs in the U.S. market.

For further launch related queries, please contact: dguinn@best-in-class.com or sthapar@best-in-class.com